Comparative safety of pioglitazone versus clinically meaningful treatment alternatives concerning the risk of bladder cancer in older US adults with type 2 diabetes.

about

Considerations for Pharmacoepidemiological Studies of Drug-Cancer Associations.Pioglitazone use in patients with diabetes and risk of bladder cancer: a systematic review and meta-analysis.

P2860

Q47270566-3AFF8853-CCF3-4800-880A-DDA8EDA801E8 Q55406042-A53C1947-35F5-458C-90C2-07643C133DB8

P2860

Comparative safety of pioglitazone versus clinically meaningful treatment alternatives concerning the risk of bladder cancer in older US adults with type 2 diabetes.

Item

http://www.wikidata.org/entity/Q40141299

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Comparative safety of pioglita ...... S adults with type 2 diabetes.

@en

type

Item

label

Comparative safety of pioglita ...... S adults with type 2 diabetes.

@en

prefLabel

Comparative safety of pioglita ...... S adults with type 2 diabetes.

@en

P1476

Comparative safety of pioglita ...... S adults with type 2 diabetes.

@en

P2093

Jennifer L Lund

http://www.w3.org/2001/XMLSchema#string

Til Stürmer

http://www.w3.org/2001/XMLSchema#string

Virginia Pate

http://www.w3.org/2001/XMLSchema#string

P2860

Threats to validity of nonrandomized studies of postdiagnosis exposures on cancer recurrence and survival

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial

Standards of medical care in diabetes--2013

Identification of smoking using Medicare data--a validation study of claims-based algorithms

Agreement of diagnosis and its date for hematologic malignancies and solid tumors between medicare claims and cancer registry data.

Treatment effects in the presence of unmeasured confounding: dealing with observations in the tails of the propensity score distribution--a simulation study.

Pioglitazone Use and Risk of Bladder Cancer and Other Common Cancers in Persons With Diabetes.

Pioglitazone use and risk of bladder cancer: population based cohort study.

Thiazolidinedione-induced edema.

Assessing the association of pioglitazone use and bladder cancer through drug adverse event reporting

P304

129-140

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/DOM.13049

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

John Buse

Elizabeth M Garry

P577

2017-06-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28661561

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

P932

7037672

http://www.w3.org/2001/XMLSchema#string

Comparative safety of pioglitazone versus clinically meaningful treatment alternatives concerning the risk of bladder cancer in older US adults with type 2 diabetes.

about

P2860

P2860

Comparative safety of pioglitazone versus clinically meaningful treatment alternatives concerning the risk of bladder cancer in older US adults with type 2 diabetes.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932